
Scientific Papers Take Our Research to the World
Since its creation in 1962, Texas Heart Institute has been a leader in advancing cardiovascular medicine, making discoveries that have...
Since its creation in 1962, Texas Heart Institute has been a leader in advancing cardiovascular medicine, making discoveries that have...
As everyone is reflecting on the year and looking forward to 2022, we celebrate the best stories, news and milestones....
The impact of a scientific article is often described in terms of how many times the article has been cited...
THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...
On Wednesday, October 27th the THI/THMG Wellness Committee hosted a team pumpkin-carving contest. All Texas Heart Institute and Texas Heart...
The Smartphone Application, Developed in Partnership with AT&T, is Ranked Number 7 Overall Among Apps for Coronary Heart Disease HOUSTON,...
When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...
Cardiovascular disease (CVD) remains the world’s number one killer, resulting in 18.6 million deaths a year. From well-known risk factors...
Moderated by the Baker Institute’s Dr. Kirstin Matthews, the 2021 Session Featured Discussion on Stem Cell Policy from THI’s Dr....
Houston, TX – The Texas Heart Institute is pleased to share with the community that Aryn Knight, Administrative Director of...
Autologous bone marrow‐derived mesenchymal stromal cells (MSCs) and ckit positive cardiac cells (CPCs) show promise in Phase II study HOUSTON,...